|Articles|June 1, 2002

June 2002
Volume 8
Issue 6

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Author(s)Joy L. Meier, PharmD, Arthur L.M. Swislocki, MD, Julio R. Lopez, PharmD

Download PDF: Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Articles in this issue

over 24 years ago

Article

Robbing Tomorrow's Generations

over 24 years ago

Article

Consumer Response to a Report Card Comparing Healthcare Systems

over 24 years ago

Article

Screening for Colorectal Cancer: The Business Case

over 24 years ago

Article

A Nurse-Based Pilot Program to Reduce Cardiovascular Risk Factors in a Primary Care Setting

over 24 years ago

Article

"My Patients Are Sicker:" Using the Pra Risk Survey for Case Finding and Examining Primary Care Site Utilization Patterns in a Medicare-Risk MCO

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Articles in this issue

Related Content

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

5 Things to Know About the 2026 ESC Heart Failure Guidelines

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

MFN Drug Agreements Could Raise Prices Worldwide

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care